Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Executive Record

Robert G. Kramer, Sr.

Chief executive: Emergent BioSolutions Inc. (1 Apr 2019 to 24 Jun 2023)

11commitments announced
7with a clear outcome
5met on time
–rate shown after 15 outcomes

Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Emergent BioSolutions Inc. filing.

Commitments announced under Robert G. Kramer, Sr.

Emergent BioSolutions Inc.announced 30 May 2023 Deliver ACAM2000 smallpox vaccine to the Strategic National Stockpile due after leader left Being checked31 Dec 2023
Emergent BioSolutions Inc.announced 30 May 2023 Deliver botulism antitoxin to the Strategic National Stockpile due after leader left Being checked31 Dec 2023
Emergent BioSolutions Inc.announced 9 May 2023 Launch over-the-counter NARCAN Nasal Spray due after leader left Met30 Sep 2023
Emergent BioSolutions Inc.announced 29 Mar 2023 Make NARCAN Nasal Spray available on U.S. shelves and at online retailers due after leader left Met31 Dec 2023
Emergent BioSolutions Inc.announced 15 Feb 2023 Close the sale of the travel health business to Bavarian Nordic due after leader left Met30 Jun 2023
Emergent BioSolutions Inc.announced 1 Aug 2022 Complete the expansion project at the Rockville facility Met · disputed31 Dec 2022
Emergent BioSolutions Inc.announced 16 May 2022 Close the acquisition of TEMBEXA rights from Chimerix Late30 Jun 2022
Emergent BioSolutions Inc.announced 10 Jan 2022 Complete the Biologics License Application filing for AV7909 Met31 Dec 2022
Emergent BioSolutions Inc.announced 4 Nov 2021 Deliver remaining ACAM2000 units under the July 2021 option exercise Not met31 Dec 2021
Emergent BioSolutions Inc.announced 4 Nov 2021 Deliver additional doses of AV7909 to the Strategic National Stockpile Being checked31 Mar 2023
Emergent BioSolutions Inc.announced 11 Jan 2021 Execute at least one Phase 3 launch and one BLA or EUA filing Being checked31 Dec 2021

Is this record wrong, or are you Robert G. Kramer, Sr.? Add a statement or ask for a correction.

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.